Smartwatches and the Debate Over Blood Pressure Monitoring: A Comprehensive Analysis
In a recent study from the University of Utah Health, researchers have shed light on the limitations of relying solely on smartwatches for blood pressure screening. The findings, published in the Journal of the American Medical Association, highlight the potential pitfalls of using smartwatches as a primary diagnostic tool for hypertension.
The study, led by Professor Adam Bress, revealed that smartwatches can provide false alerts to individuals without high blood pressure while failing to detect cases of hypertension in some users. This is particularly concerning given the silent nature of hypertension, often referred to as a 'silent killer' as it is the leading cause of heart disease without noticeable symptoms.
According to a statement from U. Health, smartwatches should be seen as a supportive tool rather than a replacement for regular blood pressure checks. While the Apple Watch's hypertension notification feature, approved by the U.S. Food and Drug Administration in September, uses optical sensors to detect blood flow patterns, it is not intended for diagnosing high blood pressure.
An Apple analysis showed that the notification feature missed approximately 59% of people with undiagnosed hypertension and incorrectly alerted about 8% of individuals without hypertension. With an estimated 200 million Apple Watch users, including 30 million in the U.S., the study concluded that widespread use of this technology for hypertension diagnosis could lead to significant issues.
The research found that individuals receiving alerts were more likely to have high blood pressure. For adults under 30, the chance of having high blood pressure increased from 14% to 47% after receiving an Apple Watch alert, while for adults over 60, the chance rose from 45% to 81%. Conversely, not receiving an alert for adults over 60 lowered the chance of having high blood pressure to 34%.
The study also noted that the absence of an alert for high blood pressure can be more reassuring for younger adults but may be less reassuring for older adults or subgroups with a higher risk of hypertension. According to U. Health, adults under 40 with no additional risk factors should have a blood pressure screening every three to five years, and adults over 40 should be screened annually.
To ensure accurate diagnosis and treatment, the researchers recommend that individuals using Apple Watch devices still obtain blood pressure screenings with a traditional blood pressure cuff. When a hypertension alert is received, clinicians should conduct a 'high-quality cuff-based office blood pressure measurement' and consider additional measurements outside the office, such as home or ambulatory blood pressure monitoring, to confirm the diagnosis.
The research team plans to conduct follow-up studies to identify specific demographics associated with more false negatives and positives, aiming to enhance the accuracy and reliability of smartwatch-based blood pressure monitoring.
